Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Drug combination for treating osteoporosis

A technology for osteoporosis and composition, which can be used in drug combinations, bone diseases, pharmaceutical formulations, etc., and can solve problems such as adverse reactions

Inactive Publication Date: 2016-01-06
王秋灵
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The present invention aims at the technical defects of the prior art, and provides a pharmaceutical composition for treating osteoporosis, so as to solve the technical problem of adverse reactions of osteoporosis treatment drugs in the prior art

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] A pharmaceutical composition for treating osteoporosis, which is composed of the following ingredients in parts by weight: 9 parts of star anise maple root, 5 parts of white horse bone, 5 parts of lentil skin, 2 parts of Tibetan green fruit, 2 parts of Chuanmutong, and 2 parts of Gonggongzi , 2 parts of ghost needle grass, 2 parts of cinnamon oil, 2 parts of yellow mustard seed, and 2 parts of garlic.

Embodiment 2

[0022] A pharmaceutical composition for treating osteoporosis, which is composed of the following ingredients in parts by weight: 8 parts of star anise maple root, 4 parts of white horse bone, 4 parts of lentil skin, 1.5 parts of Tibetan green fruit, 1.5 parts of Chuanketong, and 1.5 parts of Gonggongzi , 1.5 parts of ghost needle grass, 1.5 parts of cinnamon oil, 1.5 parts of yellow mustard seed, 1.5 parts of garlic, 1.5 parts of sedum notoginseng.

Embodiment 3

[0024] A pharmaceutical composition for treating osteoporosis, which is composed of the following ingredients in parts by weight: 10 parts of star anise maple root, 6 parts of white horse bone, 6 parts of lentil skin, 2.5 parts of Tibetan green fruit, 2.5 parts of Chuanketong, and 2.5 parts of Gonggongzi , 2.5 parts of ghost needle grass, 2.5 parts of cinnamon oil, 2.5 parts of yellow mustard seed, 2.5 parts of garlic, and 2.5 parts of jushengzi.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a drug combination for treating osteoporosis. The drug combination is composed of, by weight, 8-10 parts of Chinese alangium root, 4-6 parts of Serissa serissoides, 4-6 parts of hyacinth bean coat, 1.5-2.5 parts of myrobalan, 1.5-2.5 parts of clematis armandii, 1.5-2.5 parts of Mahonia bealei carr, 1.5-2.5 parts of sticktight, 1.5-2.5 parts of cinnamon oil, 1.5-2.5 parts of Brassica juncea seed and 1.5-2.5 parts of Chinese buttercup. The components are integrated, and the using amount of each component is designed in an optimized manner, so that the drug combination can effectively improve bone compactness and relieve osteoporosis symptoms and has the advantages of quick action and freeness of adverse reaction. Further, experiment results show that better drug absorption is facilitated when the drug combination is taken in a powdery manner; sedum aizoon or sesamum indicum is further added on the basis of a formula, so that further improving of treatment effect is facilitated.

Description

technical field [0001] The invention relates to the technical field of orthopedic disease treatment, in particular to a pharmaceutical composition for treating osteoporosis. Background technique [0002] Osteoporosis is a group of bone diseases caused by various reasons. Bone tissue has normal calcification, and the ratio of calcium salt to matrix is ​​normal. It is a metabolic bone lesion characterized by a decrease in the amount of bone tissue per unit volume. In most cases of osteoporosis, the loss of bone tissue is mainly due to increased bone resorption. The onset is mostly slow and individual is relatively fast, characterized by bone pain and easy fracture, and the biochemical examination is basically normal. Pathological anatomy shows that the bone cortex is thin, the trabecular bone is sparse and atrophic, and the osteoid layer is not thick. Traditional Chinese medicine believes that it is caused by deficiency of liver and kidney, and malnutrition of muscles and bo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/74A61P19/10
Inventor 王秋灵邹勇
Owner 王秋灵
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products